Partner Sites

Login Subscribe Today

SubscribeSubscribe Today

LISAbio

We empower diagnostic laboratories to grow and thrive in the evolving regulatory landscape.

Article by LISAbio

Filter by

All Article Audio Document Event Infographic Survey Video

Image of pegs surrounding money. Crowdfunding assays for UTIs are the initial offering from LISA in response to the FDA’s LDT final rule.

|2 min read

Initial Crowdfunding Assays Are Now Available in Response to LDT Final Rule

LISA heads up new effort with UTI assays designed to comply with the FDA’s regulations for lab-developed tests

Image showing coins surrounding an idea lightbulb. The Laboratory Integration Strategic Association is leading an effort to crowdsource LDT development in reaction to FDA regulations.

|3 min read

First Ever Effort to Crowdfund Diagnostic Assays Launches in Response to FDA LDT Final Rule

LISA CEO explains why crowdfunding is a viable way to shoulder the new regulatory costs behind laboratory-developed tests

Page 1 of 1

Sponsored

Thumbnail

What's Ahead for Laboratory Reimbursement: PAMA, Payer Scrutiny, and Compliance Risk in 2027

Gloved laboratory professional handling blood sample tubes in a clinical diagnostics lab

Four Companies Transforming Point-of-Care Molecular Diagnostics in 2026

Thumbnail

When the Sample Waits: Pre-Analytical Variability in Multi-Analyte Blood Testing

Clinical scientist working with a clinical analyzer

Protecting Clinical Lab Uptime